RE­PORTS

EQUUS - - Conversati­ons -

Although the Food and Drug Ad­min­is­tra­tion ap­proval process en­sures that a new drug meets ef­fi­cacy and safety stan­dards, “real world” us­age of­ten re­veals even more about its most use­ful ap­pli­ca­tions. Although the bis­pho­s­pho­nates have been widely avail­able in this coun­try for only a short time, vet­eri­nar­i­ans are al­ready in­te­grat­ing th­ese med­i­ca­tions into their treat­ment plans.

“Til­dren is what I have the most ex­pe­ri­ence with,” says Court­ney Wit­tich, DVM, of Hag­yard Equine Med­i­cal In­sti­tute in Lex­ing­ton, Ken­tucky. “I started us­ing it when it had to be im­ported.”

Wit­tich, like many vet­eri­nar­i­ans, of­ten uses Til­dren in an “off-la­bel” way not de­scribed in the prod­uct lit­er­a­ture. “I’ll give it to horses with ax­ial skele­tal is­sues, like back and neck bone-re­lated pain,” she says. “And when I’m us­ing it for nav­ic­u­lar, I’ll typ­i­cally give it as part of a re­gional limb per­fu­sion.” A tech­nique that de­liv­ers a high con­cen­tra­tion of a med­i­ca­tion through an in­tra­venous in­jec­tion be­low the level of a tourni­quet, re­gional limb per­fu­sion is also com­monly used for tar­get­ing an­tibi­otic treat­ments.

Whether Til­dren is ad­min­is­tered sys­tem­i­cally or lo­cally, Wit­tich and her

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.